Fresenius Medical Care AG

18.88+0.0300+0.16%Vol 384.88K1Y Perf -52.92%
Aug 12th, 2022 16:00 DELAYED
BID18.61 ASK19.20
Open18.90 Previous Close18.85
Pre-Market- After-Market18.88
 - -  - -%
Target Price
30.18 
Analyst Rating
Hold 3.00
Potential %
59.85 
Finscreener Ranking
★★★     48.94
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     48.28
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     49.94
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★     43.60
Price Range Ratio 52W %
3.17 
Earnings Rating
Sell
Market Cap11.08B 
Earnings Date
29th Jul 2022
Alpha-0.02 Standard Deviation0.08
Beta1.21 

Today's Price Range

18.7218.94

52W Range

18.1640.85

5 Year PE Ratio Range

8.4026.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
1.07%
1 Month
-18.62%
3 Months
-35.36%
6 Months
-41.64%
1 Year
-52.92%
3 Years
-43.64%
5 Years
-58.82%
10 Years
-46.21%

TickerPriceChg.Chg.%
FMS18.880.03000.16
AAPL172.123.63002.15
GOOG122.652.83002.36
MSFT291.914.89001.70
XOM94.000.81000.87
WFC45.940.69001.52
JNJ165.30-1.8400-1.10
FB196.640.99000.51
GE79.931.03001.31
JPM122.131.99001.66
 
ProfitabilityValueIndustryS&P 500US Markets
28.20
9.30
18.50
11.50
5.72
RevenueValueIndustryS&P 500US Markets
18.98B
32.35
1.58
0.18
DividendsValueIndustryS&P 500US Markets
3.76
0.71
8.60
11.43
Payout ratio31.00
Earnings HistoryEstimateReportedSurprise %
Q02 20220.450.41-8.89
Q01 20220.300.3826.67
Q04 20210.500.512.00
Q03 20210.540.551.85
Q02 20210.510.46-9.80
Q01 20210.450.5113.33
Q04 20200.700.768.57
Q03 20200.660.717.58
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.45-10.00Negative
9/2022 QR0.51-10.53Negative
12/2022 FY1.89-9.13Negative
12/2023 FY2.19-6.41Negative
Next Report Date-
Estimated EPS Next Report0.45
Estimates Count1
EPS Growth Next 5 Years %13.10
Volume Overview
Volume384.88K
Shares Outstanding586.83K
Shares Float586.06M
Trades Count4.06K
Dollar Volume7.25M
Avg. Volume808.28K
Avg. Weekly Volume601.19K
Avg. Monthly Volume1.03M
Avg. Quarterly Volume796.86K

Fresenius Medical Care AG (NYSE: FMS) stock closed at 18.88 per share at the end of the most recent trading day (a 0.16% change compared to the prior day closing price) with a volume of 384.88K shares and market capitalization of 11.08B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 125364 people. Fresenius Medical Care AG CEO is Rice Powell.

The one-year performance of Fresenius Medical Care AG stock is -52.92%, while year-to-date (YTD) performance is -41.84%. FMS stock has a five-year performance of -58.82%. Its 52-week range is between 18.16 and 40.85, which gives FMS stock a 52-week price range ratio of 3.17%

Fresenius Medical Care AG currently has a PE ratio of 12.40, a price-to-book (PB) ratio of 0.77, a price-to-sale (PS) ratio of 0.58, a price to cashflow ratio of 4.80, a PEG ratio of 2.32, a ROA of 2.34%, a ROC of 3.88% and a ROE of 6.28%. The company’s profit margin is 5.72%, its EBITDA margin is 18.50%, and its revenue ttm is $18.98 Billion , which makes it $32.35 revenue per share.

Of the last four earnings reports from Fresenius Medical Care AG, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.45 for the next earnings report. Fresenius Medical Care AG’s next earnings report date is -.

The consensus rating of Wall Street analysts for Fresenius Medical Care AG is Hold (3), with a target price of $30.18, which is +59.85% compared to the current price. The earnings rating for Fresenius Medical Care AG stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fresenius Medical Care AG has a dividend yield of 3.76% with a dividend per share of $0.71 and a payout ratio of 31.00%.

Fresenius Medical Care AG has a Sell technical analysis rating based on Technical Indicators (ADX : 10.61, ATR14 : 0.65, CCI20 : -49.24, Chaikin Money Flow : -0.05, MACD : -1.57, Money Flow Index : 37.92, ROC : -16.05, RSI : 36.58, STOCH (14,3) : 15.58, STOCH RSI : 1.00, UO : 37.49, Williams %R : -84.42), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fresenius Medical Care AG in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (16.67 %)
1 (20.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (66.67 %)
3 (60.00 %)
3 (60.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
1 (20.00 %)
Strong Sell
1 (16.67 %)
1 (20.00 %)
1 (20.00 %)
Summary RatingHold
3.00
Hold
3.00
Moderate Sell
3.60

Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

CEO: Rice Powell

Telephone: +49 61726082522

Address: Else-Kroener-Strasse 1, Bad Homburg 61352, , DE

Number of employees: 125 364

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

48%52%

Bearish Bullish

77%23%


News

Stocktwits